Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_provenance.
- NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_assertion description "[Reliable studies on animal models indicate that the proteolytic break-down products of apolipoprotein[a] would posses anti-angiogenic and anti-tumoral properties both in vitro and in vivo, a premise to develop novel therapeutic modalities which may efficiently suppress tumor growth and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_provenance.
- NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_assertion evidence source_evidence_literature NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_provenance.
- NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_assertion SIO_000772 17442497 NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_provenance.
- NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_assertion wasDerivedFrom befree-20150227 NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_provenance.
- NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_assertion wasGeneratedBy ECO_0000203 NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP539099.RAPJZtJ3QGG7_4kHEudv5QtLUBi8uE9MAY23LtYwqEQTM130_provenance.